<DOC>
	<DOC>NCT02797665</DOC>
	<brief_summary>This study evaluates corticosteroids in the treatment of obstructive jaundice in autoimmune pancreatitis and/or immunoglobulin G4 (IgG4)-related sclerosing cholangitis in adults. Half of participants will receive corticosteroids alone, while the other half will receive corticosteroids with biliary stent at the beginning.</brief_summary>
	<brief_title>Treatment of Obstructive Jaundice in Autoimmune Pancreatitis and/or Immunoglobulin G4-related Sclerosing Cholangitis by Corticosteroids</brief_title>
	<detailed_description />
	<mesh_term>Pancreatitis</mesh_term>
	<mesh_term>Cholangitis</mesh_term>
	<mesh_term>Cholangitis, Sclerosing</mesh_term>
	<mesh_term>Jaundice</mesh_term>
	<mesh_term>Jaundice, Obstructive</mesh_term>
	<criteria>adults greater than 18 yearsold; autoimmune pancreatitis and/or IgG4related sclerosing cholangitis; obstructive jaundice malignancies; active infections; pregnancy or breast feeding; standard contraindications to ERCP; unwillingness or inability to consent for the study</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>June 2016</verification_date>
</DOC>